Feil Family Brain & Mind Research Institute

Publications

Found 8 results
Author Title Type [ Year(Desc)]
Filters: Author is Fetcho, Robert N  [Clear All Filters]
2017
Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A et al..  2017.  Resting-state connectivity biomarkers define neurophysiological subtypes of depression.. Nat Med. 23(1):28-38.
2018
Che A, Babij R, Iannone AF, Fetcho RN, Ferrer M, Liston C, Fishell G, García NVDe Marco.  2018.  Layer I Interneurons Sharpen Sensory Maps during Neonatal Development.. Neuron. 99(1):98-116.e7.
2019
Bavley CC, Fetcho RN, Burgdorf CE, Walsh AP, Fischer DK, Hall BS, Sayles NM, Contoreggi NH, Hackett JE, Antigua SA et al..  2019.  Cocaine- and stress-primed reinstatement of drug-associated memories elicit differential behavioral and frontostriatal circuit activity patterns via recruitment of L-type Ca channels.. Mol Psychiatry.
Bavley CC, Fetcho RN, Burgdorf CE, Walsh AP, Fischer DK, Hall BS, Sayles NM, Contoreggi NH, Hackett JE, Antigua SA et al..  2019.  Correction: Cocaine- and stress-primed reinstatement of drug-associated memories elicit differential behavioral and frontostriatal circuit activity patterns via recruitment of L-type Ca channels.. Mol Psychiatry.
Duan ZRan S, Che A, Chu P, Modol L, Bollmann Y, Babij R, Fetcho RN, Otsuka T, Fuccillo MV, Liston C et al..  2019.  GABAergic Restriction of Network Dynamics Regulates Interneuron Survival in the Developing Cortex.. Neuron.
2020
Bavley CC, Fetcho RN, Burgdorf CE, Walsh AP, Fischer DK, Hall BS, Sayles NM, Contoreggi NH, Hackett JE, Antigua SA et al..  2020.  A dual-virus strategy for the deletion of cacan1c within the prelimbic to nucleus accumbens core projection.. Mol Psychiatry. 25(10):2201-2202.
2023
Babij R, Ferrer C, Donatelle A, Wacks S, Buch AM, Niemeyer JE, Ma H, Duan ZRan S, Fetcho RN, Che A et al..  2023.  Gabrb3 is required for the functional integration of pyramidal neuron subtypes in the somatosensory cortex.. Neuron. 111(2):256-274.e10.
2024
Martinez-Rivera A, Fetcho RN, Birmingham L, Jiu JX, Yang R, Foord C, Scala-Chávez D, Mekawy N, Pleil K, Pickel VM et al..  2024.  Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia.. bioRxiv.